Ticker Details
Merck & Co., Inc. Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$303B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.53 | 0.90%
Avg Daily Range (30 D):	$1.12 | 0.94%
Avg Daily Range (90 D):	$1.14 | 1.02%

Institutional Daily Volume
Avg Daily Volume:	10.57M
Avg Daily Volume (30 D):	6.84M
Avg Daily Volume (90 D):	8.95M

Trade Size
Avg Trade Size (Sh.):	170
Avg Trade Size (Sh.) (30 D):	60
Avg Trade Size (Sh.) (90 D):	67

Institutional Trades
Total Institutional Trades:	174,607
Avg Institutional Trade:	$5.87M
Avg Institutional Trade (30 D):	$18.82M
Avg Institutional Trade (90 D):	$16.29M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	30

Market Closing Trades
Avg Closing Trade:	$85.25M
Avg Closing Trade (30 D):	$252.95M
Avg Closing Trade (90 D):	$243.07M
Avg Closing Volume:	1.15M

News

Apr 10, 2026 @ 2:57 PM Sun Pharma Nears Final Offer For Organon In Larges... Source: Vandana Singh

Apr 10, 2026 @ 8:43 AM Crohn's Disease Eight-Market Drug Forecast and Mar... Source: Researchandmarkets.Com

Apr 7, 2026 @ 6:28 PM Merck Lowered Terns Pharmaceuticals Offer Price Af... Source: Vandana Singh

Apr 7, 2026 @ 4:46 PM What's Going On With Merck Stock Tuesday? Source: Nabaparna Bhattacharya

Apr 7, 2026 @ 12:00 PM Evaxion announces last patient visit in one-year e... Source: Not Specified

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$7.3	$1.21	$7.3
Diluted EPS	$7.28	$1.2	$7.28
Revenue	$65.01B	$16.4B	$65.01B
Gross Profit	$48.63B	$10.85B	$48.63B
Net Income / Loss	$18.26B	$2.96B	$18.26B
Operating Income / Loss	$21.07B	$3.42B	$21.07B
Cost of Revenue	$16.38B	$5.55B	$16.38B
Net Cash Flow	$1.37B	$-3570M	$1.37B
PE Ratio	16.58